Remimazolam

Generic Name
Remimazolam
Brand Names
Byfavo
Drug Type
Small Molecule
Chemical Formula
C21H19BrN4O2
CAS Number
308242-62-8
Unique Ingredient Identifier
7V4A8U16MB
Background

Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotran...

Indication

Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.

Associated Conditions
Procedural Sedation
Associated Therapies
-
Clinical Trials
Related News

Dose of Remimazolam in Children for Intubation

Not Applicable
Not yet recruiting
Conditions
Anesthesia
Interventions
Drug: Remimazolam
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
Zhihong LU
Target Recruit Count
40
Registration Number
NCT06170918

Comparison of Procedural Sedation in TEE

Phase 1
Not yet recruiting
Conditions
Anesthesia
Interventions
Drug: Remimazolam
Drug: Propofol
First Posted Date
2023-11-13
Last Posted Date
2024-10-10
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
120
Registration Number
NCT06129188

ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children

Not Applicable
Completed
Conditions
Bidirectional Endoscopy
Interventions
Drug: Remimazolam
First Posted Date
2023-11-08
Last Posted Date
2024-10-26
Lead Sponsor
Tongji Hospital
Target Recruit Count
114
Registration Number
NCT06121609
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Not Applicable
Recruiting
Conditions
Postoperative Delirium
Interventions
Drug: Remimazolam
Drug: Propofol
First Posted Date
2023-11-02
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
696
Registration Number
NCT06115031
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

First Posted Date
2023-10-31
Last Posted Date
2024-04-16
Lead Sponsor
Tianjin Medical University General Hospital
Target Recruit Count
400
Registration Number
NCT06108830
Locations
🇨🇳

Tianjin Medical University General Hospital, Tianjin, China

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

Not Applicable
Completed
Conditions
Prostate Tumor
Interventions
Drug: remimazolam
Drug: Propofol
First Posted Date
2023-10-23
Last Posted Date
2024-12-12
Lead Sponsor
Yonsei University
Target Recruit Count
112
Registration Number
NCT06093971
Locations
🇰🇷

Yonsei University College of Medicine, Seoul, Korea, Republic of

The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation

First Posted Date
2023-10-23
Last Posted Date
2023-10-23
Lead Sponsor
The Second Affiliated Hospital of Hainan Medical University
Target Recruit Count
150
Registration Number
NCT06095570
Locations
🇨🇳

The Second Affiliated Hospital of Hainan Medical University, Hai Kou, China, Haikou, Hainan, China

COnventional vs. Optimised PERiprocedural Analgosedation vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)

Phase 3
Recruiting
Conditions
Atrial Fibrillation
Interventions
Drug: Propofol
Drug: Remimazolam
First Posted Date
2023-08-28
Last Posted Date
2023-11-28
Lead Sponsor
Charles University, Czech Republic
Target Recruit Count
126
Registration Number
NCT06013345
Locations
🇨🇿

University Hospital Kralovske Vinohrady, Prague, Czechia

Effects of Remimazolam and Propofol on Anesthesia Induction

Not Applicable
Recruiting
Conditions
Diabetes
Interventions
Drug: Remimazolam
Drug: Propofol
First Posted Date
2023-08-24
Last Posted Date
2024-01-25
Lead Sponsor
Zheng Guo
Target Recruit Count
80
Registration Number
NCT06009055
Locations
🇨🇳

econd of Shanxi Medical University, Taiyuan, Shanxi, China

The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients

Not Applicable
Not yet recruiting
Conditions
Hypoxia
Hysteroscopy
Overweight or Obesity
Interventions
Drug: remimazolam
Drug: Propofol
First Posted Date
2023-08-22
Last Posted Date
2023-08-28
Lead Sponsor
RenJi Hospital
Target Recruit Count
600
Registration Number
NCT06004843
Locations
🇨🇳

Renji Hospital, Shanghai, Pudong New Area, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy